SFA
VRTX icon

Sequoia Financial Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

Sequoia Financial Advisors’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.31M Buy
16,729
+1,831
+12% +$811K 0.04% 252
2026
Q1 		$6.65M Buy
14,898
+1,302
+10% +$607K 0.04% 269
2025
Q4 		$6.16M Sell
13,596
-384
-3% -$166K 0.03% 281
2025
Q3 		$5.48M Sell
13,980
-393
-3% -$164K 0.03% 287
2025
Q2 		$6.4M Buy
14,373
+442
+3% +$204K 0.04% 244
2025
Q1 		$6.75M Buy
13,931
+1,041
+8% +$485K 0.05% 232
2024
Q4 		$5.19M Buy
12,890
+602
+5% +$279K 0.05% 253
2024
Q3 		$5.72M Buy
12,288
+1,147
+10% +$551K 0.06% 206
2024
Q2 		$5.22M Buy
11,141
+334
+3% +$145K 0.06% 185
2024
Q1 		$4.52M Sell
10,807
-3,569
-25% -$1.51M 0.06% 206
2023
Q4 		$5.85M Buy
14,376
+11,448
+391% +$4.23M 0.07% 198
2023
Q3 		$1.02M Buy
2,928
+199
+7% +$69.6K 0.02% 332
2023
Q2 		$960K Buy
2,729
+260
+11% +$87.6K 0.02% 354
2023
Q1 		$778K Buy
2,469
+110
+5% +$33K 0.02% 362
2022
Q4 		$681K Buy
2,359
+1,399
+146% +$426K 0.02% 372
2022
Q3 		$278K Buy
960
+20
+2% +$5.75K 0.01% 403
2022
Q2 		$265K Buy
+940
New +$252K 0.01% 478

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Sequoia Financial Advisors's VRTX Position: Q2 2026 in Review

Sequoia Financial Advisors increased its Vertex Pharmaceuticals (VRTX) stake by 12% in Q2 2026, buying an estimated $811K and bringing the position to 16,729 shares worth $8.31M. The position accounts for 0.04% of the portfolio, ranked #252.

Sequoia Financial Advisors first reported a position in VRTX in Q2 2022 and has held it in 17 quarters since. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Sequoia Financial Advisors held 16,729 shares of Vertex Pharmaceuticals worth $8.31M as of Q2 2026.
  • Sequoia Financial Advisors bought 1,831 Vertex Pharmaceuticals shares in Q2 2026, an estimated $811K.
  • Vertex Pharmaceuticals made up 0.04% of Sequoia Financial Advisors's portfolio in Q2 2026, its #252 holding.
  • Sequoia Financial Advisors first reported a position in Vertex Pharmaceuticals in Q2 2022 and has held it in 17 quarters since.
  • 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Sequoia Financial Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.